ABPro Bio Co

ABPro Bio Co Equity

The The Equity of ABPro Bio Co (195990.KQ) as of Oct 8, 2026 is 54.03 B KRW. In the previous year, The Equity was 108.01 B KRW — a change of -49.98% (lower).

Equity

54.03 BKRW

YoY

-49.98%

Last updated:

In 2025, ABPro Bio Co's equity was 54.03 B KRW, a -49.98% increase from the 108.01 B KRW equity in the previous year.

The ABPro Bio Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
106.88 B KRW
Jan 1, 2019
118.43 B KRW
Jan 1, 2020
139.10 B KRW
Jan 1, 2021
137.54 B KRW
Jan 1, 2022
140.20 B KRW
Jan 1, 2023
122.34 B KRW
Jan 1, 2024
108.01 B KRW
Jan 1, 2025
54.03 B KRW
The ABPro Bio Co Equity history
YEAREquityYoY
54.03 BKRW-49.98%
108.01 BKRW-11.71%
122.34 BKRW-12.74%
140.20 BKRW+1.93%
137.54 BKRW-1.12%
139.10 BKRW+17.45%
118.43 BKRW+10.81%
106.88 BKRW+9.47%
97.64 BKRW-10.96%
109.66 BKRW+5.60%
103.84 BKRW+56.92%
66.17 BKRW—
Access this data via the Eulerpool API
Get Free API Key

ABPro Bio Co Stock analysis

What does ABPro Bio Co do? ABPro Bio Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing ABPro Bio Co's Equity

ABPro Bio Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ABPro Bio Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ABPro Bio Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ABPro Bio Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ABPro Bio Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ABPro Bio Co stock

The Equity of ABPro Bio Co is 54.03 B KRW in 2025.

The Equity of ABPro Bio Co changed from 108.01 B KRW to 54.03 B KRW, representing a -49.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity ABPro Bio Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's ABPro Bio Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — ABPro Bio Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — ABPro Bio Co